CDG Invest Growth announced its exit from Laboratoires Steripharma, a well-established pharmaceutical business in Morocco through a strategic sale.
Steripharma was founded in 1999 and has since developed a large portfolio of drugs with strong recognition among patients and practitioners. The Company has its own range of medicines (generics) and also produces/distributes drugs under license for leading international laboratories. Its product range covers major therapeutic areas, including infectiology and parasitology, cardiology, respiratory system, digestive system, dental care, ophthalmology and dermatology.
Click here for more information about Steripharma
